Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

IgA Vasculitis (Henoch-Schönlein Purpura)

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

IgA Vasculitis (Henoch-Schönlein Purpura)

Porsha Roache-Robinson et al.
Free Books & Documents

Excerpt

Immunoglobulin A vasculitis (IgAV), formerly Henoch-Schönlein purpura, involves the small vessels of the joints, kidneys, gastrointestinal tract, and skin. IgAV can also affect the central nervous system and the lungs; however, these findings are rare. It is an acute IgA-mediated disorder typically self-limited and managed with supportive care; however, serious complications, such as renal failure, can occur.

Henoch-Schönlein purpura is named after the German physician, Dr. Johann Schönlein and his student Eduard Henoch. Schönlein identified the association between joint pain and purpura, and Henoch identified gastrointestinal and renal involvement. Although Henoch-Schönlein purpura is named after Henoch and Schönlein, an English physician named William Heberden was the first to describe the disorder in the early 1800s. Iga vasculitis is now the preferred term due to a tendency toward etiology-based rather than eponym-based nomenclature.

Of note, IgA vasculitis with nephritis has many overlapping features with IgA nephropathy, which is the most common glomerulonephritis in the world. The primary differences are that IgAV with nephritis is more likely to first occur in children younger than 15, while IgA nephropathy usually has an onset in patients older than 15. IgAV with nephritis is more likely to present with extrarenal symptoms; IgA nephropathy presents more often with gross hematuria. Histology in IgAV with nephritis shows more capillary staining and glomerular injury than in IgA nephropathy.

Finally, IgAV with nephritis has a 98% clinical remission; comparatively, patients with IgA nephropathy progress to end-stage renal disease within 20 years of diagnosis in 30% to 50% of cases. Another interesting difference is that IgAV with nephritis presents more often during the winter "cold" season, while IgA nephropathy does not show seasonality. Much of the difference between the two disease processes results from IgAV being predominantly a disease of children and IgA nephropathy being primarily a disease of adults.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Porsha Roache-Robinson declares no relevant financial relationships with ineligible companies.

Disclosure: Robert Killeen declares no relevant financial relationships with ineligible companies.

Disclosure: David Hotwagner declares no relevant financial relationships with ineligible companies.

References

    1. Trnka P. Henoch-Schönlein purpura in children. J Paediatr Child Health. 2013 Dec;49(12):995-1003. - PubMed
    1. Rajasekaran A, Julian BA, Rizk DV. IgA Nephropathy: An Interesting Autoimmune Kidney Disease. Am J Med Sci. 2021 Feb;361(2):176-194. - PMC - PubMed
    1. Selvaskandan H, Shi S, Twaij S, Cheung CK, Barratt J. Monitoring Immune Responses in IgA Nephropathy: Biomarkers to Guide Management. Front Immunol. 2020;11:572754. - PMC - PubMed
    1. Sestan M, Jelusic M. Diagnostic and Management Strategies of IgA Vasculitis Nephritis/Henoch-Schönlein Purpura Nephritis in Pediatric Patients: Current Perspectives. Pediatric Health Med Ther. 2023;14:89-98. - PMC - PubMed
    1. Reamy BV, Williams PM, Lindsay TJ. Henoch-Schönlein purpura. Am Fam Physician. 2009 Oct 01;80(7):697-704. - PubMed

Publication types

LinkOut - more resources